Real-world evaluation of bevacizumab plus platinum and paclitaxel for advanced cervical cancer: a single-arm study from Syria
This study supports the effectiveness of bevacizumab-based therapy as a first-line option in the Syrian setting, showing sustained clinical benefit and reinforcing the relevance of international guidelines in local oncology practice.
Authors
- Maher Saifo (ORCID: https://orcid.org/0000-0002-5418-3186)
- Bana Mohamad
Institutions
- Damascus Hospital (SY)
- Damascus University (SY)
Publication Details
- Journal
- ecancermedicalscience
- Published
- 2026-01-22
- DOI
- https://doi.org/10.3332/ecancer.2026.2066
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00